DekaBank DG Index/Partizip. Zert .../ DE000DK07CK8 /
6/3/2024 1:11:13 PM | Chg.+0.640 | Bid2:07:53 PM | Ask2:07:53 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
75.400EUR | +0.86% | 75.440 Bid Size: 100,000 |
75.640 Ask Size: 10,000 |
BAYER AG NA O.N. | 37.94 EUR | 10/10/2025 | Call |
GlobeNewswire
8:30 AM
Orion is developing the Finnish life science industry in a unique collaboration project
GlobeNewswire
8:00 AM
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Pract...
GlobeNewswire
5/30
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
5/30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
5/2
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire
4/18
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire
4/16
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
4/11
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
3/25
BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire
3/6
BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
GlobeNewswire
3/4
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
GlobeNewswire
2/13
Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire
2/13
First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure